May 29 (Reuters) - Johnson & Johnson ( JNJ ) said on Wednesday its experimental therapy, seltorexant, met all main and secondary goals in a late-stage study evaluating it in patients with major depressive disorder (MDD) and insomnia symptoms. The therapy was given as a supplemental treatment to antidepressants in the study. ...

By Jesús Aguado and Andres Gonzalez MADRID/LONDON (Reuters) - Spain's Sabadell is not planning to try and buy a competitor as part of a potential defence strategy against rival BBVA's hostile takeover attempt, Chief Executive Officer Cesar Gonzalez-Bueno told Reuters. Spain's No. 2 lender BBVA this month stunned Spain by making the first hostile takeover attempt in Spanish banking since...

LONDON, May 29 (Reuters) - Shell and Exxon Mobil ( XOM ) are nearing an agreement to sell their jointly-owned gas fields in the southern North Sea to independent British producer Viaro Energy, three industry and banking sources said. The potential deal is valued around $500 million, one of the sources said. The sale of the Clipper and Leman Alpha...

FRANKFURT, May 29 (Reuters) - COVID-19 vaccine maker BioNTech has secured up to $145 million in funding from a global coalition against infectious diseases to build a production network in Africa for shots based on cutting-edge messenger-RNA (mRNA) technology. BioNTech and the Coalition for Epidemic Preparedness Innovations (CEPI) said in a joint statement on Wednesday that the financial support was...